|
Transgene - Company Profile Snapshot
| Company Profile: |
Transgene |
| Ticker: |
MGIC |
| Exchanges: |
PAR |
| 2008 Sales: |
3,388,000 |
| Major Industry: |
Miscellaneous |
| Sub Industry: |
Medical Services |
| Country: |
FRANCE |
| Employees: |
241 |
Business Description
Transgene. The Group's principal activity is to discover and develop therapeutic vaccines. The Group develops gene-based vaccines used in treatment of cancer and infectious diseases. The Group follows three different strategies. The Group develops vaccines and partners with pharmaceutical companies for further development. The Group also independently develops and commercializes vaccines for certain special markets. The third strategy is to license vector technologies to companies with proprietary genes for short and medium term revenues. The Group markets the products under the brand names MYoDys, TG 4010, TG 4001, TG 1042 and TG 4040. The Group operates mainly in France.
|
Not the Report you are looking for?
Click here for more browsing options.
|
The following information is available to subscribers or can be accessed by purchasing the Company Profile Report:
|
- Address (mailing), Phone Number, Web Address
- Earnings/Dividends
- Employees
- Exchanges Listed
- Financial Ratio Analysis |
- Recent Stock Performance
- Sales (recent year)
- Senior Officers
- Shareholder Information
- Stock Analysis Summary |
Layout and Content of a Typical Report
|
|
|
|
|
